These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 17366781)
1. [Immunotherapeutic effect of recombinant EGFR phage vaccine on tumors]. Liu D; Tang L; Zhou CC; Tan LS Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):728-32. PubMed ID: 17366781 [TBL] [Abstract][Full Text] [Related]
2. [An anti-tumor research of recombinant phage vaccine expressed xenogenic EGFR]. Zeng XZ; Liu D; Tang L; Zhou CC; Tan LS; Cai XH; Li XW; Zhou JN; Zhang PD; Zhang SQ Shi Yan Sheng Wu Xue Bao; 2005 Dec; 38(6):481-9. PubMed ID: 16416965 [TBL] [Abstract][Full Text] [Related]
3. [Antitumor effect of recombinant T7 phage vaccine expressing xenogenic vascular endothelial growth factor on Lewis lung cancer in mice]. Li XH; Tang L; Liu D; Sun HM; Zhou CC; Tan LS; Wang LP; Zhang PD; Zhang SQ Ai Zheng; 2006 Oct; 25(10):1221-6. PubMed ID: 17059764 [TBL] [Abstract][Full Text] [Related]
4. [Expression of xenogentic epidermal growth factor receptor ectodomain and its antitumor effect]. Li YH; Tang L; Liu Q; Chen DK; Tan LS Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Nov; 24(11):1051-4. PubMed ID: 18992189 [TBL] [Abstract][Full Text] [Related]
5. Immunogene therapy of tumors with vaccine based on xenogeneic epidermal growth factor receptor. Lu Y; Wei YQ; Tian L; Zhao X; Yang L; Hu B; Kan B; Wen YJ; Liu F; Deng HX; Li J; Mao YQ; Lei S; Huang MJ; Peng F; Jiang Y; Zhou H; Zhou LQ; Luo F J Immunol; 2003 Mar; 170(6):3162-70. PubMed ID: 12626574 [TBL] [Abstract][Full Text] [Related]
6. Cancer immunotherapy by a recombinant phage vaccine displaying EGFR mimotope: an in vivo study. Asadi-Ghalehni M; Ghaemmaghami M; Klimka A; Javanmardi M; Navari M; Rasaee MJ Immunopharmacol Immunotoxicol; 2015 Jun; 37(3):274-9. PubMed ID: 25990849 [TBL] [Abstract][Full Text] [Related]
7. A novel recombinant anti-epidermal growth factor receptor peptide vaccine capable of active immunization and reduction of tumor volume in a mouse model. Asadi-Ghalehni M; Rasaee MJ; RajabiBazl M; Khosravani M; Motaghinejad M; Javanmardi M; Khalili S; Modjtahedi H; Sadroddiny E Microbiol Immunol; 2017 Dec; 61(12):531-538. PubMed ID: 29023946 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of tumor angiogenesis in lung cancer by T4 phage surface displaying mVEGFR2 vaccine. Ren S; Fengyu ; Zuo S; Zhao M; Wang X; Wang X; Chen Y; Wu Z; Ren Z Vaccine; 2011 Aug; 29(34):5802-11. PubMed ID: 21482223 [TBL] [Abstract][Full Text] [Related]
9. [Transformation activity and antigenicity of the human papillomavirus type 58 E6E7 fusion gene mutant]. Wang H; Yu JY; Li L Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):491-6. PubMed ID: 24257298 [TBL] [Abstract][Full Text] [Related]
10. Construction of a Recombinant Phage-vaccine Capable of Reducing the Growth Rate of an Established LL2 Tumor Model. Asadi-Ghalehni M; Rasaee MJ; Namvar Asl N; Khosravani M; Rajabibazl M; Khalili S; Modjtahedi H; Sadroddiny E Iran J Allergy Asthma Immunol; 2018 Jun; 17(3):240-249. PubMed ID: 29908541 [TBL] [Abstract][Full Text] [Related]
11. Immunization with tumor neoantigens displayed on T7 phage nanoparticles elicits plasma antibody and vaccine-draining lymph node B cell responses. Shukla GS; Sun YJ; Pero SC; Sholler GS; Krag DN J Immunol Methods; 2018 Sep; 460():51-62. PubMed ID: 29906453 [TBL] [Abstract][Full Text] [Related]
12. B-cell epitope peptide vaccination targeting dimer interface of epidermal growth factor receptor (EGFR). Zhu L; Zhao L; Wu M; Chen Z; Li H Immunol Lett; 2013 Jun; 153(1-2):33-40. PubMed ID: 23871733 [TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of endogenous mFlt4 displayed on a T4 phage nanoparticle surface. Ren SX; Ren ZJ; Zhao MY; Wang XB; Zuo SG; Yu F Acta Pharmacol Sin; 2009 May; 30(5):637-45. PubMed ID: 19417736 [TBL] [Abstract][Full Text] [Related]
14. [Construction and immunological analysis of a combined multi-epitope vaccine against EGFR/HER2]. Hu CP; Cai XT; Lu WG; Wang ZG; Ji XY; Cao P Yao Xue Xue Bao; 2011 Nov; 46(11):1326-31. PubMed ID: 22260023 [TBL] [Abstract][Full Text] [Related]
15. [High expression of HPV16L2N120E7E6 fusion protein in E. coli and its inhibitory effect on tumor growth in mice]. Zhao L; Gao M; Gao J; Ren J; Zhang H; Tian HW; Tan WJ; Ruan L Zhonghua Zhong Liu Za Zhi; 2012 Nov; 34(11):810-5. PubMed ID: 23291127 [TBL] [Abstract][Full Text] [Related]
16. Anti-tumour research of recombinant BCG using BZLF1 and hGM-CSF fusion genes. Xue QJ; Li YQ; Yang CQ; Chen T; Li XZ; Cheng B; Wang CM Vaccine; 2017 Mar; 35(12):1599-1607. PubMed ID: 28228322 [TBL] [Abstract][Full Text] [Related]
17. Induction of anti-EGFR immune response with mimotopes identified from a phage display peptide library by panitumumab. Wang A; Cui M; Qu H; Di J; Wang Z; Xing J; Wu F; Wu W; Wang X; Shen L; Jiang B; Su X Oncotarget; 2016 Nov; 7(46):75293-75306. PubMed ID: 27659529 [TBL] [Abstract][Full Text] [Related]
18. [Antitumor effect of EGFRvIII/HBcAg recomibinant vaccine on murine transplanted tumor]. Duan XY; Wang JS; Guo YM; Wang P; Wang QY; Yang GX Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jul; 23(7):600-2. PubMed ID: 17618576 [TBL] [Abstract][Full Text] [Related]
19. [Preliminary observation on antitumor effect of HPV58 composite DNA vaccine]. Wang H; Yu JY; Li L Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):523-7. PubMed ID: 24284225 [TBL] [Abstract][Full Text] [Related]
20. [Construction and immunogenicity of recombinant bacteriophage T7 vaccine expressing M2e peptides of avian influenza virus]. Xu H; Wang YW; Tang YH; Zheng QS; Hou JB Bing Du Xue Bao; 2013 Jun; 29(4):376-81. PubMed ID: 23895000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]